- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00006162
Lifestyle Interventions to Reduce Diabetes Risk
March 1, 2010 updated by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Interventions to Reduce Diabetic Risk in Japanese Americans
Type 2 diabetes is more frequent in Japanese Americans than in Japan or the U.S. non-Hispanic white population.
This appears to be due to the effects of ''westernization'' to bring out metabolic changes that lead to diabetes.
This study will look at whether increased physical activity and dietary changes will reduce or prevent the metabolic changes that lead to type 2 diabetes in Japanese Americans who have impaired glucose tolerance, a condition intermediate between normal glucose tolerance and diabetes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Japanese American
- Confirmed impaired glucose tolerance
- Able to fill out questionnaires
Exclusion Criteria:
- Significant exercise-restricting disease
- Poorly controlled hypertension
- Psychiatric disease or dementia
- Already on unusually restrictive diet
- Use of hypolipidemic drugs
- Use of tobacco
- Abnormal blood screening tests
- ECG evidence of ischemic heart disease at rest
- Abnormal maximal Bruce treadmill test
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 1994
Study Completion
April 1, 1999
Study Registration Dates
First Submitted
August 8, 2000
First Submitted That Met QC Criteria
August 8, 2000
First Posted (Estimate)
August 9, 2000
Study Record Updates
Last Update Posted (Estimate)
March 2, 2010
Last Update Submitted That Met QC Criteria
March 1, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- fujimotow (completed)
- 1R01DK048152 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
AstraZenecaRecruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
Clinical Trials on exercise and diet
-
Göteborg UniversityThe Swedish Research Council; Swedish Council for Working Life and Social ResearchCompleted
-
Florida International UniversityTerminatedDiabetes | Frailty | Senior SyndromeUnited States
-
Rabin Medical CenterSoroka University Medical Center; D-Cure, IsraelCompleted
-
University of PittsburghUniversity of PennsylvaniaCompleted
-
USDA Grand Forks Human Nutrition Research CenterWithdrawn
-
Changi General HospitalCompletedQuality of Life | Inflammation | Sexual Dysfunction | Endothelial DysfunctionSingapore
-
Universidade Católica PortuguesaAssociação para o Desenvolvimento do Centro Académico de Investigação e Formação...Active, not recruitingCardiovascular Disease RiskPortugal
-
American Scitech InternationalProactive Clinical ResearchUnknownType II Diabetes MellitusUnited States, India
-
University of AlexandriaCompleted
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Completed